ClinicalTrials.Veeva

Menu

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

A

Aljazeera Hospital

Status

Unknown

Conditions

Myoma

Treatments

Drug: women receiving misoprostol
Drug: women receiving tranexamic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT04694677
Myomectomy

Details and patient eligibility

About

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Full description

Although most of them are asymptomatic, 20-50% of fibroids may cause problems such as heavy menstrual bleeding, anemia, pelvic pain, pressure symptoms from extrinsic compression of the colorectal and urinary tract, infertility, and recurrent pregnancy losses, where surgical intervention is often indicated

Enrollment

60 estimated patients

Sex

Female

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women with myomas

Exclusion criteria

  • with with malignant lesions

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

women receiving tranexamic acid
Active Comparator group
Treatment:
Drug: women receiving tranexamic acid
women receiving misoprostol
Active Comparator group
Treatment:
Drug: women receiving misoprostol

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoud Alalfy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems